[1]
T. Sahin and E. Kocak, “The safety of alpha fetoprotein in diagnosis of hepatocellular carcinoma in patients with type 2 diabetes mellitus ”, annalsmedres, vol. 26, no. 12, pp. 2961–2965, May 2021.